Autosomal‐dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Autosomal‐dominant Alzheimer's disease (ADAD) is a genetic disorder caused by mutations in Amyloid Precursor Protein (APP) or Presenilin (PSEN) genes. Studying the mechanisms underlying these mutations can provide insight into the pathways that lead to AD pathology. The majority of biochemical studies on APP mutations to‐date have focused on comparing mechanisms between mutations at different codons. It has been assumed that amino acid position is a major determinant of protein dysfunction and clinical phenotype. However, the differential effect of mutations at the same codon has not been sufficiently addressed. In the present study we compared the effects of the aggressive ADAD‐associated APP I716F mutation with I716V and I716T on APP processing in human neuroglioma and CHO‐K1 cells. All APP I716 mutations increased the ratio of Aβ42/40 and changed the product line preference of γ‐secretase towards Aβ38 production. In addition, the APP I716F mutation impaired the ε‐cleavage and the fourth cleavage of γ‐secretase and led to abnormal APP β‐CTF accumulation at the plasma membrane. Taken together, these data indicate that APP mutations at the same codon can induce diverse abnormalities in APP processing, some resembling PSEN 1 mutations. These differential effects could explain the clinical differences observed among ADAD patients bearing different APP mutations at the same position. image The amyloid precursor protein (APP) I716F mutation is associated with autosomal dominant Alzheimer's disease with the youngest age‐at‐onset for the APP locus. Here, we describe that this mutation, when compared to two other familial Alzheimer's disease mutations at the same codon (I716V and I716T), interfered distinctly with γ‐secretase cleavage. While all three mutations direct γ‐secretase cleavage towards the 48→38 production line, the APP I716F mutation also impaired the ε‐cleavage and the fourth cleavage of γ‐secretase, resembling a PSEN1 mutation. These features may contribute to the aggressiveness of this mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · cited 1×
“(2014) 128, 330--339 PSEN1 and PSEN2, although PSEN1/c- secretase-containing complexes are the major contributors to Ab production in the CNS (De Strooper et al. 1998; Franberg et al. 2011; Borgegard et al. 2012).”
BackgroundIwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774 · cited 1×
“Taken together, this supports the role of Ab40 in the formation of cored plaques, and that mutations that drastically reduce Ab40 and elevate the ratio Ab42/40, would lead to predominant Ab42-immunoreactive diffuse plaques (Iwatsubo et al. 1994).”
ResultThe 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., et al. (2001) · Nature Neuroscience · doi:10.1038/nn0901-887 · Cited by 1,209 · cited 2×
“Flemish, Italian, Dutch, Arctic and Iowa) result in an Ab peptide which either has a greater tendency to aggregate (Fraser et al. 1992; Nilsberth et al. 2001) or equally, a greater resistance to degradation (Morelli et al.”
BackgroundTrafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075 · cited 3×
“This is consistent with the observation that c-secretase cleaves APP on the cell surface and endosomes/ lysosomes (Haass et al. 2012) and our previous data on the I716F mutation in cell culture and in human brain samples © 2013 International Society for Neurochemistry, J. Neurochem.”
BackgroundResultInfluentialNeurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907
Campion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., Thomas-Anterion, C., Michon, A., Martin, C., Charbonnier, F., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302553 · Cited by 785 · cited 1×
“Most studies have assessed the pathogenic mechanism underlying APP mutations comparing mutations in different codons of APP (Campion et al. 1999; Janssen et al. 2003; Zekanowski et al. 2003; Raux et al. 2005; Guerreiro et al. 2010).”
BackgroundHaass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L., & Selkoe, D. J. (1995) · Nature Medicine · doi:10.1038/nm1295-1291 · Cited by 592 · cited 2×
“A group of mutations found near the b-secretase cleavage site (e.g. the double Swedish mutation KM670/671/NL) have been shown to direct APP processing towards the amyloidogenic pathway, resulting in increased b-secretase cleavage and total Ab production (Haass et al. 1995).”
BackgroundBateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573
The mechanism of γ‐Secretase dysfunction in familial Alzheimer disease
Chávez‐Gutiérrez, L., Bammens, L., Benilova, I., Vandersteen, A., Benurwar, M., Borgers, M., Lismont, S., Zhou, L., Van Cleynenbreugel, S., Esselmann, H., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.79 · Cited by 495 · cited 7×
“We found that all APP716 mutations change the product line preference of c-secretase towards the Ab38 line, which is in general agreement with previous studies (Chavez-Gutierrez et al. 2012).”
BackgroundMethodResultInfluentialInhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
vom Berg, J., Prokop, S., Miller, K. R., Obst, J., Kälin, R. E., Lopategui-Cabezas, I., Wegner, A., Mair, F., Schipke, C. G., Peters, O., et al. (2012) · Nature Medicine · doi:10.1038/nm.2965 · Cited by 416
Qi-Takahara, Y., Morishima-Kawashima, M., Tanimura, Y., Dolios, G., Hirotani, N., Horikoshi, Y., Kametani, F., Maeda, M., Saido, T. C., Wang, R., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1575-04.2005 · Cited by 391 · cited 1×
“According to the model proposed by Qi-Takahara et al. (Sato et al. 2003; Qi-Takahara et al. 2005), the c-secretase cleavage of the b-CTF is also sequential; firstly the e-cleavage generates Ab48 or Ab49 and the intracellular fragment of APP (AICD).”
MethodA New Pathogenic Mutation in the APP Gene (I716V) Increases the Relative Proportion of A 42(43)
Eckman, C. B., Mehta, N. D., Crook, R., Perez-tur, J., Prihar, G., Pfeiffer, E., Graff-Radford, N., Hinder, P., Yager, D., Zenk, B., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2087 · Cited by 236
De Jonghe, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1665 · Cited by 223 · cited 1×
“(2014) 128, 330--339 (range 18-100-fold), whereas the I716T and I716V (De Jonghe et al. 2001; Eckman et al. 2001) mutations produce a milder effect (2.7 and 1.3-2-fold, respectively).”
BackgroundInfluentialMitani, Y., Yarimizu, J., Saita, K., Uchino, H., Akashiba, H., Shitaka, Y., Ni, K., & Matsuoka, N. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4264-11.2012 · Cited by 203 · cited 2×
“…and long-term memory in mouse animal models of AD (Yankner et al. 1989; Oster-Granite et al. 1996; McPhie et al. 1997; Kim et al. 2003; Saura et al. 2005; Jiang et al. 2010; Lauritzen et al. 2012; Mitani et al. 2012), therefore, it likely represents an active component of ADAD (Pera et al. 2012).”
BackgroundLauritzen, I., Pardossi-Piquard, R., Bauer, C., Brigham, E., Abraham, J.-D., Ranaldi, S., Fraser, P., St-George-Hyslop, P., Le Thuc, O., Espin, V., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2775-12.2012 · Cited by 201 · cited 2×
“…and long-term memory in mouse animal models of AD (Yankner et al. 1989; Oster-Granite et al. 1996; McPhie et al. 1997; Kim et al. 2003; Saura et al. 2005; Jiang et al. 2010; Lauritzen et al. 2012; Mitani et al. 2012), therefore, it likely represents an active component of ADAD (Pera et al. 2012).”
BackgroundKumar-Singh, S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2589 · Cited by 158 · cited 3×
“Biochemical studies in human embryonic kidney (HEK) 293T cells (Kumar-Singh et al. 2000) showed similarities with the findings of the APP I716F mutation studied herein.”
BackgroundResultSaura, C. A., Chen, G., Malkani, S., Choi, S.-Y., Takahashi, R. H., Zhang, D., Gouras, G. K., Kirkwood, A., Morris, R. G. M., & Shen, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1247-05.2005 · Cited by 157
Cited by
Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development
Chen, G.-F., Xu, T.-H., Yan, Y., Zhou, Y.-R., Jiang, Y., Melcher, K., & Xu, H. E. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.28 · Cited by 1,965
The amyloid cascade hypothesis: an updated critical review
Kepp, K. P., Robakis, N. K., Høilund-Carlsen, P. F., Sensi, S. L., & Vissel, B. (2023) · Brain · doi:10.1093/brain/awad159 · Cited by 284
Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders
Cai, Y., Arikkath, J., Yang, L., Guo, M.-L., Periyasamy, P., & Buch, S. (2016) · Autophagy · doi:10.1080/15548627.2015.1121360 · Cited by 258
Ringman, J. M., Monsell, S., Ng, D. W., Zhou, Y., Nguyen, A., Coppola, G., Van Berlo, V., Mendez, M. F., Tung, S., Weintraub, S., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv028 · Cited by 99
“The specific differences in APP processing that account for the more aggressive AD pathology seen in ADAD are unclear because qualitative differences have been shown in APP processing between ADAD and sAD (37–39) and even between APP mutations at the same codon (40).”
BackgroundGenetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
Dominantly Inherited Alzheimer Network, Ringman, J. M., Goate, A., Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., & Morris, J. C. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0499-8 · Cited by 96
Metadata
- Authors
- Suárez‐Calvet, M., Belbin, O., Pera, M., Badiola, N., Magrané, J., Guardia‐Laguarta, C., Muñoz, L., Colom‐Cadena, M., Clarimón, J., & Lleó, A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2013-10-24
- Volume
- 128
- Issue
- 2
- Pages
- 330-339
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1968366631
- Cited by
- 41
- References
- 17
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.